Evidence map›Paper›PMID 26830207›Full record

ArticleTissue engineering. Part A2016

Promoting Endochondral Bone Repair Using Human Osteoarthritic Articular Chondrocytes.

Chelsea S Bahney, Linsey Jacobs, Robert Tamai, Diane Hu, Tammy F Luan, Miqi Wang, Sanjay Reddy, Michelle Park, Sonja Limburg, Hubert T Kim and 2 more

Abstract read
In one paragraph

Article in Tissue engineering. Part A, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Chelsea S Bahney1 The Orthopaedic Trauma Institute, San Francisco General Hospital, University of California , San Francisco, San Francisco, California.
Linsey Jacobs2 San Francisco Veterans Affairs Medical Center, University of California , San Francisco, San Francisco, California.
Robert Tamai2 San Francisco Veterans Affairs Medical Center, University of California , San Francisco, San Francisco, California.
Diane Hu1 The Orthopaedic Trauma Institute, San Francisco General Hospital, University of California , San Francisco, San Francisco, California.
Tammy F Luan2 San Francisco Veterans Affairs Medical Center, University of California , San Francisco, San Francisco, California.
Miqi Wang2 San Francisco Veterans Affairs Medical Center, University of California , San Francisco, San Francisco, California.
Sanjay Reddy2 San Francisco Veterans Affairs Medical Center, University of California , San Francisco, San Francisco, California.
Michelle Park2 San Francisco Veterans Affairs Medical Center, University of California , San Francisco, San Francisco, California.
Sonja Limburg2 San Francisco Veterans Affairs Medical Center, University of California , San Francisco, San Francisco, California.
Hubert T Kim2 San Francisco Veterans Affairs Medical Center, University of California , San Francisco, San Francisco, California.
Ralph Marcucio1 The Orthopaedic Trauma Institute, San Francisco General Hospital, University of California , San Francisco, San Francisco, California.
Alfred C Kuo2 San Francisco Veterans Affairs Medical Center, University of California , San Francisco, San Francisco, California.
University of California, San Francisco · USUniversity of California System · USSan Francisco VA Medical Center · US

Funding

Tissue engineering application of endochondral ossification for bone regenerationF32AR062469 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BAHNEY, CHELSEA SHIELDS · 2012 to 2014
$106k
NIAMS NIH HHS 5F32AR062469
6 · The paper itself

Abstract

introductionCurrent tissue engineering strategies to heal critical-size bone defects through direct bone formation are limited by incomplete integration of grafts with host bone and incomplete graft vascularization. An alternative strategy for bone regeneration is the use of cartilage grafts that form bone through endochondral ossification. Endochondral cartilages stimulate angiogenesis and are remodeled into bone, but are found in very small quantities in growth plates and healing fractures. We sought to develop engineered endochondral cartilage grafts using osteoarthritic (OA) articular chondrocytes as a cell source. Such chondrocytes often undergo hypertrophy, which is a characteristic of endochondral cartilages. MATERIALS AND

methodsWe compared the ability of unmodified human OA (hOA) cartilage and cartilage grafts formed in vitro from hOA chondrocytes to undergo endochondral ossification in mice. Scaffold-free engineered chondrocyte grafts were generated by pelleting chondrocytes, followed by culture with transforming growth factor-β1 (TGF-β1) and bone morphogenetic protein 4. Samples derived from either primary or passaged chondrocytes were implanted subcutaneously into immunocompromised mice. Grafts derived from passaged chondrocytes from three patients were implanted into critical-size tibial defects in mice. Bone formation was assessed with histology after 4 weeks of implantation. The composition of tibial repair tissue was quantified with histomorphometry.

resultsEngineered cartilage grafts generated from passaged OA chondrocytes underwent endochondral ossification after implantation either subcutaneously or in bone. Cartilage grafts integrated with host bone at 15 out of 16 junctions. Grafts variably remodeled into woven bone, with the proportion of bony repair tissue in tibial defects ranging from 22% to 85% (average 48%). Bony repair tissue bridged the tibial defects in half of the animals. In contrast, unmodified OA cartilage and engineered grafts formed from primary chondrocytes did not undergo endochondral ossification in vivo.

conclusionshOA chondrocytes can adopt an endochondral phenotype after passaging and TGF-β superfamily treatment. Engineered endochondral cartilage grafts can integrate with host bone, undergo ossification, and heal critical-size long-bone defects in a mouse model. However, additional methods to further enhance ossification of these grafts are required before the clinical translation of this approach.

Indexed as

Wound HealingAnimalsBone and BonesCartilage, ArticularChondrocytesGene Expression RegulationHumansIntercellular Signaling Peptides and ProteinsMiceOsteoarthritisOsteocalcinPhenotypeTibiaTissue EngineeringIntercellular Signaling Peptides and ProteinsOsteocalcin

Identifiers

PMID26830207
PMCPMC4800268
OpenAlexW2272113816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.